Search Results
Dr. Kris Discusses Role of Antiangiogenesis in Lung Cancer
Dr. Kris Describes the Use of Genetic Testing in Lung Cancer
Mark Kris, MD: Antiangiogenic Therapy in NSCLC
The Current Role for Antiangiogenic Therapy for NSCLC
How Does Antiangiogenic Therapy Work?
Dr. Kris on Combination Chemotherapy Approaches in NSCLC
Dr. Kris on the Future of Immunotherapy and Targeted Therapy in Lung Cancer
Dr. Kris Discusses the Pemetrexed Clincal Trial Results
Dr. Mark Kris on Immunotherapy and Frontline Options for Patients With NSCLC
Dr. Kris on the RELAY Trial in EGFR+ NSCLC
Advice for Treating Patients With Lung Cancer
Current Concepts in Anti-Angiogenic Therapy for Non-Small Cell Lung Cancer
